Embolotherapy for Neuroendocrine Tumors

Neuroendocrine tumors.

Neuroendocrine tumors comprise a broad family of tumors, the most common of which are carcinoid and pancreatic neuroendocrine tumors. The NCCN Neuroendocrine Tumors Guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine tumors. Most of the recommendations pertain to well-differentiated, low- to intermediate-grade tumors. This updated version of the NCCN G...

Biochemical testing for neuroendocrine tumors.

In this review, we focus on the use of biochemical markers for the diagnosis of neuroendocrine tumors and exclusion of conditions that masquerade as neuroendocrine tumors. In addition, we outline the use of biochemical markers for follow-up, response to intervention, and determination of prognosis. Previous publications have focused only on markers specific to certain tumor types, but the uniqu...

Neuroendocrine Tumors

Nalân Utku1* and Ulrich Frank Pape2 1Campus Virchow Institute for Medical Immunology, Institutsgebäude Süd Föhrer, 213353 Berlin, Germany 2Campus Mitte and Virchow, Charité Comprehensive Cancer Center and Gastrophatology2, Charite, Berlin, Germany *Corresponding author: Nalân Utku, Campus Virchow Institute for Medical Immunology, Institutsgebäude Süd Föhrer, 213353 Berlin, Germany; E-mail: nala...

Developmental trends in targeted radionuclide therapy of neuroendocrine tumors

  Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms including carcinoids, pancreatic neuroendocrine tumors, pituitary tumors, medullary thyroid carcinoma and phaeochromocytomas. The symptoms and the outcome of NETs differ considerably between patients depending on several factors. By labelling tracers with a radioisotope, the tracer acts as a ...

Bronchial Neuroendocrine Tumors